Dr. Emily Stevens
My research focuses on the genetics, toxins, and evolution of opportunistic pathogens within the host microbiome using GWAS and experimental evolution approaches.
King, K.C., Stevens, E., Drew, G.C. 2020. Microbiome: evolution in a world of interaction. Current Biology 30, R265-R267.
Yokoyama, M., Stevens, E. et al., 2018. Epistasis analysis uncovers hidden antibiotic resistance-associated fitness costs hampering the evolution of MRSA. Genome Biology, 19. DOI: 10.1186/s13059-018-1469-2.
Stevens, E. et al., 2017. Cytolytic toxin production by Staphylococcus aureus is dependent upon the activity of the protoheme IX farnesyltransferase. Scientific Reports 7. DOI: 10.1038/s41598-017-14110-8.
Recker, M., Laabei, M., Toleman, M., Reuter, S., Saunderson, R.B., Blane, B., Török, M.E., Ouadi, K., Stevens, E. et al., 2017. Clonal differences in Staphylococcus aureus bacteraemia-associated mortality. Nature Microbiology 2, 1381-1388. DOI: 10.1038/s41564-017-0001-x.
2020 PhD University of Bristol – “Investigating the genetic basis for bacterial toxin production using functional genomics”
2015 BSc Biology University of Bath
2019 2nd Prize for oral presentation, Staphylococcus Great Britain & Ireland (StaphGBI) conference at University of Warwick
2019 2nd Prize for poster, School of Cellular & Molecular Medicine away day at University of Bristol
2016 1st Prize for poster, University of Bath Graduate Research Afternoon